Sunday, September 13, 2020

BREAST CANCER RESEARCH RIGHT NOW! #75: European Honeybee Venom Can Stop Cancer Cell Growth!

From the first moment my wife discovered she had breast cancer, there was a deafening silence from the men I know. Even ones whose wives, mothers or girlfriends had breast cancer seemed to have received a gag order from some Central Cancer Command and did little more than mumble about the experience. Not one to shut up for any known reason, I started this blog…

Every month, I’ll be highlighting breast cancer research that is going on RIGHT NOW! Harvested from different websites, journals and podcasts, I’ll translate them into understandable English and share them with you. Today: Honeybee venom and breast cancer cells…

PLEASE NOTE THAT THIS IS AN INITIAL STUDY! THERE’S NO TREATMENT YET – AND GETTING STUNG BY A HONEYBEE WILL NOT BE THE PROCEDURE!

“Western Australia's Chief Scientist Professor Peter Klinken said, ‘This is an incredibly exciting observation that melittin, a major component of honeybee venom, can suppress the growth of deadly breast cancer cells, particularly triple-negative breast cancer.’

“‘Significantly, this study demonstrates how melittin interferes with signalling pathways within breast cancer cells to reduce cell replication. It provides another wonderful example of where compounds in nature can be used to treat human diseases,’ he said.”

While it was demonstrated as early as early as 1950 that bee venom had the capacity to reduce tumors (the initial study was done on plants), it wasn’t for another 70 years passed that researchers thought to try it on cancer cells.

Also, once the study began, it became clear that it wasn’t just “honeybee venom”, it was a component of the venom called melittin that seemed to interact with a cancer cell’s ability to communicate with other cancer cells to greatly reduce cell replication.

Melittin is the main part of honeybee venom. The REASON a sting hurts so badly is that melittin and other parts of the venom attack cell walls to burst them. The resulting cellular fluid leaks out, obviously killing the cell. This creates an allergic reaction, which is when your body releases a protein that grabs onto the offending substance, in this case the venom. It can also prevent cells from reproducing, which is usually by division, which melittin interferes with.

During the initial testing – which was done with cells in a petri dish, followed by using mice who have been specially bred to grow tumors that can be tested. “A specific concentration of honeybee venom can induce 100% cancer cell death, while having minimal effects on normal cells.” They also discovered that when using an active molecule found in the venom, the melittin, “…can completely destroy cancer cell membranes within 60 minutes.”

All of this is exciting – but again, it’s far from a solution. The cells most susceptible to this treatment are “…triple-negative breast cancer and HER2-enriched breast cancer cells.”

While this is important, researchers know that there are several types of breast cancer. Carcinoma in situ is growth of low-grade cancerous or precancerous cells within  particular place, like the mammary duct without invasion of the surrounding tissue. In contrast, invasive carcinoma does not confine itself to the initial tissue compartment and can be found in several places, including nearby lymph nodes; metastatic breast cancer has spread beyond the breast and lymph nodes and may be in the bones, lungs, liver, brain, or skin (the five most common forms of metastatic bc).

As well, there are places on the surface of and inside of a breast cancer cell that can receive different kinds of chemicals that affect how the cell can act and react. Different cells can get messages based on the kinds of places on the cell – these places are called “receptors”. They can get messages from estrogen (ER), progesterone (PR), and HER2. ER+ cancer cells depend on estrogen for their growth, so they can be treated with drugs to block estrogen. ER positive and PR positive cancer victims have the best prognosis and make up about 83% of breast cancer types.

HER2+ breast cancers are generally more aggressive than HER2- breast cancers. HER2+ cancer cells respond to drugs and can now be effectively treated. However, cells that don’t have ER, PR or HER2+ are called triple-negative and are by far the most difficult to treat. They make up less than 5% of all breast cancers. Honeybee venom CAN treat this kind of breast cancer, and it appears it can treat it effectively.

At any rate, we will be keeping close eyes on the use of honeybee venom as a breast cancer treatment.


No comments:

Post a Comment